Docsity
Docsity

Prepara tus exámenes
Prepara tus exámenes

Prepara tus exámenes y mejora tus resultados gracias a la gran cantidad de recursos disponibles en Docsity


Consigue puntos base para descargar
Consigue puntos base para descargar

Gana puntos ayudando a otros estudiantes o consíguelos activando un Plan Premium


Orientación Universidad
Orientación Universidad


Determinación de la Bilirrubina Total y Directa mediante el método colorimétrico con DMSO, Apuntes de Comunicación

El procedimiento para determinar la concentración de bilirrubina total y directa en muestras biológicas mediante un método colorimétrico que utiliza dimetilsulfóxido (dmso). El principio de la reacción química, las precauciones a tomar, la preparación de las muestras y el procedimiento para obtener resultados precisos. Además, se proporcionan datos sobre la sensibilidad, especificidad y precisión del método, así como una lista de fármacos y sustancias interferentes.

Tipo: Apuntes

2021/2022

Subido el 12/07/2022

draara
draara 🇵🇪

5

(2)

4 documentos

1 / 2

Toggle sidebar

Esta página no es visible en la vista previa

¡No te pierdas las partes importantes!

bg1
Bilirubin Total and Direct
DMSO. Colorimetric
BSIS36-I 28/06/11 SPINREACT,S.A./S.A.U. Ctra.Santa Coloma, 7 E-17176 SANT ESTEVE DE BAS (GI) SPAIN
Tel. +34 972 69 08 00 Fax +34 972 69 00 99. e-mail: [email protected]
BILIRUBIN T&D
Quantitative determination of bilirubin
IVD
Store at 2-8ºC
PRINCIPLE OF THE METHOD
Bilirubin is converted to colored azobilirubin by diazotized sulfanilic acid and
measured photometrically. Of the two fractions presents in serum, bilirubin-
glucuromide and free bilirubin loosel y bound t o albumin, only t he former reacts
directly in aqueous solution (bilirubin direct), while free bilirubin requires
solubilization with dimethylsulfoxide (DMSO) to react (bi lirubin indirect). In the
determination of indirec t bilirubin the direct is als o determined, the results
correspond to total bilirubin.
The intensity of the color formed is proportional to the bilirrubin concentration in
the sample1,2.
CLINICAL SIGNIFICANCE
Bilirubin is a breakdown product of hemoglobin.
It is transported from the spleen to the liver and excreted into bil e.
Hyperbilirubinemia results from the i ncrease of bilirubin concentrations in
plasma. Causes of hyperbilirubinemia:
Total bilirubin (T): Increase hemolysis, genetic errors , neonatal jaundice,
ineffective erythrpoiesis, and drugs.
Direct bilirubin (D): Hepatic cholestasis, genetic errors, hepatocellular
damage1,5,6.
Clinical diagnosis should not be made on a s ingle test result; it should i ntegrate
clinical and other laboratory data.
REAGENTS
R 1 (D)
Sulfanilic acid
Hydrochloric acid (HCl)
R 2 (T)
Sulfanilic acid
Hydrochloric acid (HCl)
Dimethylsulfoxide (DMSO)
R 3
Sodium nitrite
Optional
BILIRRUBIN CAL Ref: 1002250
PRECAUTIONS
R1/R2/RT: Corrosive (C):R35:Causes severe burns.
S26: In case of contact with eyes, rinse immedi ately with plenty of water and
seek medical advice.
PREPARATION
All the reagents are ready to use.
STORAGE AND STABILITY
All the components of the kit are stable until the expiration date on the label
when stored ti ghtly closed at 2-8ºC, protected from light and contaminations
prevented during their use. Do not use reagents over the expirati on date.
Signs of reagent deterioration:
- Presence of particles and turbidity.
- Color development in R 2.
ADDITIONAL EQUIPMENT
- Spectrophotometer or colorimeter measuring at 555 nm.
- Matched cuvettes 1.0 cm light path.
- General laboratory equipment.
SAMPLES
Serum or plasma, free of haemolysis (s eparated from red blood cells as s oon as
possible). Protect samples from direct light.
Sample Stabili ty (without red blood cells): 2-8ºC for 4 days and 2 months at
20ºC.
PROCEDURE
1. Assay conditions:
Wavelength: . . . . . . . . . . . . . … . . . . 555 nm (530-580)
Cuvette: . . . . . . . . . . . . . . . ... . . … … . . .1 cm light path
Temperature . . . . . . . . . . . . . . . . . . . . . . . . . . . 15-25ºC
2. Adjust the instrument to zero with distilled water.
3. Pipette into a cuvette:
Blank
Total B.
Blank
Direct B.
R 1 (D) (mL)
--
--
1.5
1.5
R 2 (T) (mL)
1.5
1.5
--
--
R 3 ( L)
--
50
--
50
Sample(Note 1) / Calibrator
(L)
100
100
100
100
4. Mix and incubate exactly for 5 minutes at 15-25ºC.
5. Read the absorbance (A).
CALCULATIONS
With Calibrator:
BlankCalibrator)A(Calibrator)A(
BlankSample)A(Sample)A(
x Conc. Calibrator = mg/dL bilirubi n
With Factor:
((A) Sample - (A) Sample Blank) x Factor* = mg/dL bilirubin in the sam ple
*Factor:
BlankCalibrator)A(Calibrator)A(
CalibratorofionConcentrat
Theoretical factor: Bilirubin (T) = 19,1 ; Bilir ubin (D) = 14
Conversion factor: mg/dL x 17.1 = mol/L.
QUALITY CONTROL
Control sera are recommended to monitor the performance of ass ay procedures:
SPINTROL H Normal and Pathologic (Ref. 1002120 and 1002210).
If control values are found outside the defined range, check the instrument, reagents
and calibrator for problems.
Each laboratory should establish its own Qual ity Control scheme and correcti ve actions
if controls do not meet the acceptable tolerances.
REFERENCE VALUES1
Bilirubin Total
Up to 1.10 mg/dL 18.81 mol/L
Bilirubin Direct
Up to 0.25 mg/dL 4.27 mol/L
These values are for orientation purpose; each laboratory sho uld establis h its own
reference range.
PERFORMANCE CHARACTERISTICS
Measuring range: From detection limit of (T) 0,099 mg/dL (D) 0.04 mg/dL to linearity
limit of 18 mg/dL.
If the results obtained were greater than linearity limi t, dilute the sample 1/2 with NaCl
9 g/L and multiply the result by 2.
Precision:
Bilirubin T
Intra-assay (n=20)
Inter-assay (n=20)
Mean (mg/dL)
1.12
5.36
1.01
5.28
SD
0.02
0.12
0.03
0.12
CV (%)
2.33
2.27
2.70
2.32
Bilirubin D
Intra-assay (n=20)
Inter-assay (n=20)
Mean (mg/dL)
0.64
2.28
0.68
2.53
SD
0.01
0.02
0.02
0.05
CV (%)
1.91
1.10
2.51
1.95
Sensitivity: 1 mg/dL = 1 mg/dL = 0.015 A (T ).
1 mg/dL = 0.073 A (D).
Accuracy: Results obtained using SPINREACT reagents did not show systematic
differences when compared with other commercial reagents.
The results obtained using 50 samples for Bilirubin D were the following:
Correlation coefficient (r): 0.99
Regression equation: y=0.9933x + 0.0039
The results obtained using 50 samples for Bilirubin T were the following:
Correlation coefficient (r): 0.996
Regression equation: y=0.0884x + 0.0208
The results of the performance characteris tics depend on the analyzer used.
INTERFERENCES
Hemolysis causes decreased bilirubin values1,2.
A li st of drugs and other interfering substances with bilirubin determination has been
reported by Young et. al3,4.
NOTES
1. For bilirubin determination i n newborns, pipette 50 L of sample. Multiply the
result by 2.
2. SPINREACT has instruction sheets for severa l au tomatic analyzers.
Instructions for many of them are available on request.
BIBLIOGRAPHY
1. Kaplan A et al . Bili rubin. Cli n Chem The C.V. Mosby Co. St Louis. Toronto.
Princeton 1984; 1238-1241. 436 and 650.
2. Malloy H T. et al. The determi nation of bilirubin with the photoelectric colorimeter.
J. Biol Chem 1937; 112, 2; 481-491.
3. Young DS. Effects of drugs on Clinical Lab. Tes ts, 4th ed AACC Press, 1995.
4. Young DS. Effects of disease on Clinical Lab. T ests, 4th ed AACC 2001.
5. Burtis A et al. Tietz Textbook of Clinical Chemistr y, 3rd ed AACC 1999.
6. Tietz N W et al. Clinical Guide to Laboratory Tests, 3rd ed A ACC 1995.
PACKAGING
Ref: 1001044
R 1 (D):
R 2 (T):
R 3:
1 x 150 mL
1 x 150 mL
1 x 10 mL
Cont.
pf2

Vista previa parcial del texto

¡Descarga Determinación de la Bilirrubina Total y Directa mediante el método colorimétrico con DMSO y más Apuntes en PDF de Comunicación solo en Docsity!

Bilirubin Total and Direct

DMSO. Colorimetric

BSIS36-I 28/06/11 SPINREACT,S.A./S.A.U. Ctra.Santa Coloma, 7 E-17176 SANT ESTEVE DE BAS (GI) SPAIN Tel. +34 972 69 08 00 Fax +34 972 69 00 99. e-mail: [email protected]

BILIRUBIN T&D

Quantitative determination of bilirubin

IVD

Store at 2-8ºC

PRINCIPLE OF THE METHOD

Bilirubin is converted to colored azobilirubin by diazotized sulfanilic acid and measured photometrically. Of the two fractions presents in serum, bilirubin- glucuromide and free bilirubin loosely bound to albumin, only the former reacts directly in aqueous solution (bilirubin direct), while free bilirubin requires solubilization with dimethylsulfoxide (DMSO) to react (bilirubin indirect). In the determination of indirect bilirubin the direct is also determined, the results correspond to total bilirubin. The intensity of the color formed is proportional to the bilirrubin concentration in the sample 1, .

CLINICAL SIGNIFICANCE

Bilirubin is a breakdown product of hemoglobin. It is transported from the spleen to the liver and excreted into bile. Hyperbilirubinemia results from the increase of bilirubin concentrations in plasma. Causes of hyperbilirubinemia: Total bilirubin (T): Increase hemolysis, genetic errors, neonatal jaundice, ineffective erythrpoiesis, and drugs. Direct bilirubin (D): Hepatic cholestasis, genetic errors, hepatocellular damage 1,5, . Clinical diagnosis should not be made on a single test result; it should integrate clinical and other laboratory data.

REAGENTS

R 1 (D)

Sulfanilic acid Hydrochloric acid (HCl)

30 mmol/L 150 mmol/L

R 2 (T)

Sulfanilic acid Hydrochloric acid (HCl) Dimethylsulfoxide (DMSO)

30 mmol/L 50 mmol/L 7 mol/L R 3 Sodium nitrite (^) 29 mmol/L

Optional BILIRRUBIN CAL Ref: 1002250

PRECAUTIONS

R1/R2/RT: Corrosive (C):R35:Causes severe burns. S26: In case of contact with eyes, rinse immediately with plenty of water and seek medical advice.

PREPARATION

All the reagents are ready to use.

STORAGE AND STABILITY

All the components of the kit are stable until the expiration date on the label when stored tightly closed at 2-8ºC, protected from light and contaminations prevented during their use. Do not use reagents over the expiration date. Signs of reagent deterioration:

  • Presence of particles and turbidity.
  • Color development in R 2.

ADDITIONAL EQUIPMENT

  • Spectrophotometer or colorimeter measuring at 555 nm.
  • Matched cuvettes 1.0 cm light path.
  • General laboratory equipment.

SAMPLES

Serum or plasma, free of haemolysis (separated from red blood cells as soon as possible). Protect samples from direct light. Sample Stability (without red blood cells): 2-8ºC for 4 days and 2 months at – 20ºC.

PROCEDURE

  1. Assay conditions: Wavelength:............. ….... 555 nm (530-580) Cuvette:............... ..... … ….. .1 cm light path Temperature........................... 15-25ºC
  2. Adjust the instrument to zero with distilled water.

3. Pipette into a cuvette:

Blank Total B. Blank Direct B. R 1 (D) (mL) -- -- 1.5 1. R 2 (T) (mL) 1.5 1.5 -- -- R 3 ( L) --^50 --^50 Sample(Note 1)^ / Calibrator ( L)

  1. Mix and incubate exactly for 5 minutes at 15-25ºC.
  2. Read the absorbance (A).

CALCULATIONS

With Calibrator:

(A)Calibrator (A)CalibratorBlank

(A)Sample (A)SampleBlank x Conc. Calibrator = mg/dL bilirubin

With Factor: ((A) Sample - (A) Sample Blank) x Factor* = mg/dL bilirubin in the sample

*Factor: (A)Calibrator (A)CalibratorBlank

ConcentrationofCalibrator

Theoretical factor: Bilirubin (T) = 19,1 ; Bilirubin (D) = 14

Conversion factor: mg/dL x 17.1 = mol/L.

QUALITY CONTROL

Control sera are recommended to monitor the performance of assay procedures: SPINTROL H Normal and Pathologic (Ref. 1002120 and 1002210). If control values are found outside the defined range, check the instrument, reagents and calibrator for problems. Each laboratory should establish its own Quality Control scheme and corrective actions if controls do not meet the acceptable tolerances.

REFERENCE VALUES

1 Bilirubin Total (^) Up to 1.10 mg/dL 18.81 mol/L Bilirubin Direct (^) Up to 0.25 mg/dL 4.27 mol/L These values are for orientation purpose; each laboratory should establish its own reference range.

PERFORMANCE CHARACTERISTICS

Measuring range: From detection limit of (T) 0,099 mg/dL (D) 0.04 mg/dL to linearity limit of 18 mg/dL. If the results obtained were greater than linearity limit, dilute the sample 1/2 with NaCl 9 g/L and multiply the result by 2. Precision: Bilirubin T Intra-assay (n=20) Inter-assay (n=20) Mean (mg/dL) 1.12 5.36 1.01 5. SD 0.02 0.12 0. 03 0. CV (%) 2. 33 2.27 2.70 2. 32

Bilirubin D Intra-assay (n=20) Inter-assay (n=20) Mean (mg/dL) 0.64 2.28 0.68 2. SD 0.01 0.02 0.02 0. CV (%) 1.91 1.10 2.51 1.

Sensitivity: 1 mg/dL = 1 mg/dL = 0.015 A (T). 1 mg/dL = 0.073 A (D). Accuracy: Results obtained using SPINREACT reagents did not show systematic differences when compared with other commercial reagents. The results obtained using 50 samples for Bilirubin D were the following: Correlation coefficient (r): 0. Regression equation: y=0.9933x + 0. The results obtained using 50 samples for Bilirubin T were the following: Correlation coefficient (r): 0. Regression equation: y=0.0884x + 0. The results of the performance characteristics depend on the analyzer used.

INTERFERENCES

Hemolysis causes decreased bilirubin values1,2. A list of drugs and other interfering substances with bilirubin determination has been reported by Young et. al 3, .

NOTES

  1. For bilirubin determination in newborns, pipette 50 L of sample. Multiply the result by 2. 2. SPINREACT has instruction sheets for several automatic analyzers. Instructions for many of them are available on request.

BIBLIOGRAPHY

  1. Kaplan A et al. Bilirubin. Clin Chem The C.V. Mosby Co. St Louis. Toronto. Princeton 1984; 1238-1241. 436 and 650.
  2. Malloy H T. et al. The determination of bilirubin with the photoelectric colorimeter. J. Biol Chem 1937; 112, 2; 481-491.
  3. Young DS. Effects of drugs on Clinical Lab. Tests, 4th ed AACC Press, 1995.
  4. Young DS. Effects of disease on Clinical Lab. Tests, 4th ed AACC 2001.
  5. Burtis A et al. Tietz Textbook of Clinical Chemistry, 3rd ed AACC 1999.
  6. Tietz N W et al. Clinical Guide to Laboratory Tests, 3rd ed AACC 1995.

PACKAGING

Ref: 1001044 R 1 (D): R 2 (T): R 3:

1 x 150 mL 1 x 150 mL 1 x 10 mL

Cont.

Bilirrubina Total y Directa

DMSO. Colorimétrico

BSIS36-E 28/06/11 SPINREACT,S.A./S.A.U. Ctra.Santa Coloma, 7 E-17176 SANT ESTEVE DE BAS (GI) SPAIN Tel. +34 972 69 08 00 Fax +34 972 69 00 99. e-mail: [email protected]

BILIRUBIN T&D

Determinación cuantitativa de bilirrubina

IVD

Conservar a 2-8ºC

PRINCIPIO DEL MÉTODO

La bilirrubina se convierte en azobilirrubina mediante el ácido sulfanílico diazotado midiéndose fotométricamente. De las dos fracciones presentes en suero, bilirrubin-glucurónido y bilirrubina libre ligada a la albúmina, sólo la primera reacciona en medio acuoso (bilirrubina directa) precisando la segunda la solubilización con dimetilsulfóxido (DMSO) para que reaccione (bilirrubina indirecta). En la determinación de la bilirrubina indirecta se determina también la directa, correspondiendo el resultado a la bilirrubina total. La intensidad del color formado es proporcional a la concentración de bilirrubina presente en la muestra ensayada1,2.

SIGNIFICADO CLÍNICO

La bilirrubina se origina por la degradación de la hemoglobina. Es transportada del bazo al hígado y se excreta en la bilis. La hiperbilirrubinemia es el resultado de un incremento de la bilirrubina en plasma. Causas más probables de la hiperbilirrubinemia: Bilirrubina Total (T): Aumento de la hemólisis, alteraciones genéticas, anemia neonatal, alteraciones eritropoyéticas, presencia de drogas. Bilirrubina Directa (D): Colestasis hepática, alteraciones genéticas y alteraciones hepáticas1,5,6. El diagnóstico clínico debe realizarse teniendo en cuenta todos los datos clínicos y de laboratorio.

REACTIVOS

R 1 (D)

Ácido sulfanílico Ácido clorhídrico (HCl)

30 mmol/L 150 mmol/L

R 2 (T)

Ácido sulfanílico Ácido clorhídrico (HCl) Dimetilsulfóxido (DMSO)

30 mmol/L 50 mmol/L 7 mol/L

R 3 (^) Sodio nitrito (^) 29 mmol/L

Opcional BILIRRUBIN CAL Ref: 1002250

PRECAUCIONES

R1/R2/RT: Corrosivo (C): R35: Provoca quemaduras graves. S26: En caso de contacto con los ojos, lávense inmediata y abundantemente con agua y acudir a un médico.

PREPARACIÓN

Todos los reactivos están listos para su uso.

CONSERVACIÓN Y ESTABILIDAD

Todos los componentes del kit son estables hasta la fecha de caducidad indicada en la etiqueta del vial, cuando se mantienen los viales bien cerrados a 2-8ºC, protegidos de la luz y se evita la contaminación durante su uso. No usar reactivos fuera de la fecha indicada. Indicadores de deterioro de los reactivos:

  • Presencia de partículas y turbidez.
  • Desarrollo de color en el R 2.

MATERIAL ADICIONAL

  • Espectrofotómetro o analizador para lecturas a 555 nm.
  • Cubetas de 1,0 cm de paso de luz.
  • Equipamiento habitual de laboratorio.

MUESTRAS

Suero o plasma libre de hemólisis (separado lo antes posible de los hematíes). Proteger de la luz. Estabilidad de la muestra separada ya de los hematíes: 4 días a 2-8ºC o 2 meses a – 20ºC.

PROCEDIMIENTO

  1. Condiciones del ensayo: Longitud de onda:............... 555 nm (530-580) Cubeta:....................... .. .1 cm paso de luz Temperatura............................ 15-25ºC
  2. Ajustar el espectrofotómetro a cero frente a agua destilada.

3. Pipetear en una cubeta:

Blanco B. Total Blanco B. Directa

R 1 (D) (mL) -- -- 1,5 1,

R 2 (T) (mL) 1,5 1,5 -- --

R 3 ( L) -- 50 -- 50

Muestra(Nota 1)/Calibrador ( L) 100 100 100 100

  1. Mezclar e incubar exactamente 5 minutos a 15-25ºC.

5. Leer la absorbancia (A).

CÁLCULOS

Con Calibrador:

(A)Calibrador (A)BlancoCalibrador

(A)Muestra (A)BlancoMuestra x Conc. Calibrador = mg/dL de bilirrubina

Con Factor: ((A) Muestra – (A) Blanco Muestra) x Factor* = mg/dL bilirrubina en la muestra

  • Factor: (A)Calibrador (A)BlancoCalibrador

ConcentracióndelCalibrador

Factor teórico: Bilirrubina (T) = 19,1 ; Bilirrubina (D) = 14

Factor de conversión: mg/dL x 17,1 = mol/L.

CONTROL DE CALIDAD

Es conveniente analizar junto con las muestras sueros control valorados: SPINTROL H Normal y Patológico (Ref. 1002120 y 1002210). Si los valores hallados se encuentran fuera del rango de tolerancia, revisar el instrumento, los reactivos y el calibrador. Cada laboratorio debe disponer su propio Control de Calidad y establecer correcciones en el caso de que los controles no cumplan con las tolerancias.

VALORES DE REFERENCIA

1 Bilirrubina Total Hasta 1,10 mg/dL 18,81 mol/L Bilirrubina Directa (^) Hasta 0,25 mg/dL 4,27 mol/L Estos valores son orientativos. Es recomendable que cada laboratorio establezca sus propios valores de referencia.

CARACTERISTÍCAS DEL MÉTODO

Rango de medida : Desde el límite de detección de (T) 0,099 mg/dL (D) 0.04 mg/dL hasta el límite de linealidad de 18 mg/dL. Si la concentración de la muestra es superior al límite de linealidad, diluir 1/2 con ClNa 9 g/L y multiplicar el resultado final por 2. Precisión : Bilirrubina T Intraserie (n= 20) Interserie (n= 20) Media (mg/dL) 1,12 5,36 1,01 5, SD 0,02 0,12 0, 03 0, CV (%) 2, 33 2,27 2 , 70 2, 32

Bilirrubina D Intraserie (n= 20) Interserie (n= 20) Media (mg/dL) 0,64 2,28 0,68 2, SD 0,01 0,02 0,02 0, CV (%) 1,91 1,10 2,51 1,

Sensibilidad analítica: 1 mg/dL = 0,015 A (T).

1 mg/dL = 0,073 A (D). Exactitud: Los reactivos SPINREACT no muestran diferencias sistemáticas significativas cuando se comparan con otros reactivos comerciales. Los resultados obtenidos con 50 muestras para Bilirrubina D fueron los siguientes: Coeficiente de correlación (r): 0. Ecuación de la recta de regresión: y=0.9933x + 0. Los resultados obtenidos con 50 muestras para Bilirrubina T fueron los siguientes: Coeficiente de correlación (r): 0. Ecuación de la recta de regresión: y=0.0884x + 0. Las características del método pueden variar según el analizador utilizado.

INTERFERENCIAS

La presencia de hemólisis disminuye el valor de bilirrubina1,2. Se han descrito varias drogas y otras substancias que interfieren con la determinación de bilirrubina 3, .

NOTAS

  1. Para la determinación de bilirrubina en neonatos, pipetear 50 L de muestra. Multiplicar el resultado obtenido por 2.

2. SPINREACT dispone de instrucciones detalladas para la aplicación de este

reactivo en distintos analizadores.

BIBLIOGRAFÍA

  1. Kaplan A et al. Bilirubin. Clin Chem The C.V. Mosby Co. St Louis. Toronto. Princeton 1984; 1238-1241. 436 and 650.
  2. Malloy H T. et al. The determination of bilirubin with the photoelectric colorimeter. J. Biol Chem 1937; 112, 2; 481-491.
  3. Young DS. Effects of drugs on Clinical Lab. Tests, 4th ed AACC Press, 1995.
  4. Young DS. Effects of disease on Clinical Lab. Tests, 4th ed AACC 2001.
  5. Burtis A et al. Tietz Textbook of Clinical Chemistry, 3rd ed AACC 1999.
  6. Tietz N W et al. Clinical Guide to Laboratory Tests, 3rd ed AACC 1995.

PRESENTACIÓN

Ref: 1001044 R 1 (D):

R 2 (T):

R 3:

1 x 150 mL

1 x 150 mL

1 x 10 mL

Cont.